# Audit Index - Workflow-to-Agent Studio

Append-only. One row per validation or review cycle.

---

## Review Schedule

| Cycle | Phase | Date | Scope | Stop-Ship | P0 | P1 | P2 |
|-------|-------|------|-------|-----------|----|----|-----|
| VAL-1 | Phase 1 | 2026-05-19 | Phase 1 artifact validation | Yes | 0 | 8 | 0 |
| VAL-2 | Phase 1 | 2026-05-19 | Phase 1 artifact validation rerun | No | 0 | 0 | 0 |
| 1 | Phase 1 | 2026-05-19 | Phase 1 implementation deep review | No | 0 | 0 | 0 |
| 2 | Phase 2 | 2026-05-19 | T07 RAG ingestion deep review | No | 0 | 0 | 1 |
| 3 | Phase 2 | 2026-05-19 | Phase 2 boundary deep review | No | 0 | 0 | 1 |
| 4 | Phase 3 | 2026-05-19 | T09 RAG ingestion deep review | No | 0 | 0 | 1 |
| 5 | Phase 3 | 2026-05-19 | T10 RAG ingestion deep review | No | 0 | 0 | 1 |
| 6 | Phase 3 | 2026-05-19 | Phase 3 boundary deep review | No | 0 | 0 | 1 |
| 7 | Phase 4 | 2026-05-19 | T14 plan schema deep review | No | 0 | 0 | 1 |
| 8 | Phase 4 | 2026-05-19 | Phase 4 boundary / T15 plan validation deep review | No | 0 | 0 | 1 |
| 9 | Phase 5 | 2026-05-19 | T16 plan validation deep review | No | 0 | 0 | 1 |
| 10 | Phase 5 | 2026-05-19 | T17 export behavior deep review | No | 0 | 0 | 1 |
| 11 | Phase 5 | 2026-05-19 | T18 RAG and plan validation deep review | No | 0 | 0 | 1 |
| 12 | Phase 5 | 2026-05-19 | Phase 5 boundary / T20 plan validation deep review | No | 0 | 0 | 1 |
| 13 | Post Phase 5 | 2026-05-19 | CODE-2 tracing fix verification | No | 0 | 0 | 0 |
| 14 | Phase 1 | 2026-05-20 | Phase 1 corpus expansion boundary review | No | 0 | 0 | 0 |

---

## Archive

| Cycle | File | Phase | Health |
|-------|------|-------|--------|
| VAL-1 | docs/audit/PHASE1_AUDIT.md | Phase 1 | Red - 8 blockers |
| VAL-2 | docs/audit/PHASE1_AUDIT.md | Phase 1 | Green - PASS |
| 1 | docs/archive/PHASE1_REVIEW.md | Phase 1 | Green - P1 resolved |
| 2 | docs/archive/CYCLE2_T07_REVIEW.md | Phase 2 / T07 | Green - 1 P2 |
| 3 | docs/archive/PHASE2_REVIEW.md | Phase 2 | Green - 1 P2 |
| 4 | docs/archive/CYCLE4_T09_REVIEW.md | Phase 3 / T09 | Green - 1 P2 |
| 5 | docs/archive/CYCLE5_T10_REVIEW.md | Phase 3 / T10 | Green - 1 P2 |
| 6 | docs/archive/PHASE3_REVIEW.md | Phase 3 | Green - 1 P2 |
| 7 | docs/archive/CYCLE7_T14_REVIEW.md | Phase 4 / T14 | Green - 1 P2 |
| 8 | docs/archive/PHASE4_REVIEW.md | Phase 4 | Green - 1 P2 |
| 9 | docs/archive/CYCLE9_T16_REVIEW.md | Phase 5 / T16 | Green - 1 P2 |
| 10 | docs/archive/CYCLE10_T17_REVIEW.md | Phase 5 / T17 | Green - 1 P2 |
| 11 | docs/archive/CYCLE11_T18_REVIEW.md | Phase 5 / T18 | Green - 1 P2 |
| 12 | docs/archive/PHASE5_REVIEW.md | Phase 5 | Green - 1 P2 |
| 13 | docs/archive/CYCLE13_CODE2_FIX.md | Post Phase 5 | Green - no open findings |
| 14 | docs/archive/CYCLE14_PHASE1_CORPUS_REVIEW.md | Phase 1 | Green - no open findings |

---

## Notes

- Phase 1 validation should write `docs/audit/PHASE1_AUDIT.md` before implementation starts.
- VAL-1 failed; blockers were resolved before implementation.
- VAL-2 passed; implementation may begin at T01.
- Optional simplification passes use a separate row prefix (`SIMP-N`) and live in `docs/audit/SIMPLIFICATION_REPORT.md`. They do not interleave with deep review cycles in this index.
